Clinical Impact of Bortezomib in Frontline Regimens for Patients with Multiple Myeloma
Open Access
- 1 August 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 12 (8) , 978-990
- https://doi.org/10.1634/theoncologist.12-8-978
Abstract
Learning Objectives: After completing this course, the reader will be able to: Discuss the efficacy of bortezomib as part of primary therapy for patients with multiple myeloma.Describe the safety of bortezomib and bortezomib-based regimens in patients with previously untreated multiple myeloma.Identify new management options for patients with treatment-naïve multiple myeloma. CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.comKeywords
This publication has 86 references indexed in Scilit:
- Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myelomaHematology, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 studyBlood, 2006
- Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trialThe Lancet, 2006
- Phase III Clinical Trial of Thalidomide Plus Dexamethasone Compared With Dexamethasone Alone in Newly Diagnosed Multiple Myeloma: A Clinical Trial Coordinated by the Eastern Cooperative Oncology GroupJournal of Clinical Oncology, 2006
- Bortezomib or High-Dose Dexamethasone for Relapsed Multiple MyelomaNew England Journal of Medicine, 2005
- PAD combination therapy (PS‐341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myelomaBritish Journal of Haematology, 2005
- Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patientsBone Marrow Transplantation, 2004
- Single versus Double Autologous Stem-Cell Transplantation for Multiple MyelomaNew England Journal of Medicine, 2003
- Review of 1027 Patients With Newly Diagnosed Multiple MyelomaMayo Clinic Proceedings, 2003